{
  "ticker": "MPA",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02975020",
  "id": "02975020",
  "pages": 8,
  "price_sensitive": true,
  "date": "20250731",
  "time": "0926",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250731/pdf/06mc72tcxzwjbx.pdf",
  "summary": "### **Mad Paws Holdings Limited \u2013 Material Information Summary**  \n\n#### **Key Highlights (Quarterly Report \u2013 Appendix 4C)**  \n- **Operating Revenue**: $6.7M (+2% pcp, +12% ex-Sash & Waggly).  \n  - Marketplace: $2.3M (+31% pcp).  \n  - Ecommerce: $4.5M (-9% pcp, +3% ex-Sash & Waggly).  \n- **Cash EBITDA**: $(0.1)M (+73% improvement pcp).  \n- **Operating Cash Flow**: +$0.8M ($1.0M improvement pcp).  \n- **Closing Cash Balance**: **$2.05M** (vs. $1.72M previous quarter).  \n- **Debt**: $2.0M drawn (BBSW + 8.6975%, min 12.0%); $0.2M repaid in quarter.  \n\n#### **Strategic Transactions**  \n- **Rover Acquisition (Scheme of Arrangement)**:  \n  - **Offer**: $0.14/share (100% cash, ~$62M equity value).  \n  - **Conditions**: Completion of Pet Chemist divestment ($13M) & closure of Sash/Waggly.  \n- **Pet Chemist Divestment**:  \n  - Sold to VetPartners for ~$13M (cash-free, debt-free).  \n\n#### **Additional Notes**  \n- **Capex**: Reduced to $0.1M (-66% pcp).  \n- **Cash Burn**: Positive operating cash flow; no immediate funding concerns.  \n\n**Summary**: Focus on Rover acquisition (pending approvals) and solid core marketplace growth.",
  "usage": {
    "prompt_tokens": 5143,
    "completion_tokens": 363,
    "total_tokens": 5506,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-30T23:37:38.039445"
}